Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-10

Clinical Trial Update: Hemodynamic Effects of Spironolactone in Patients With Heart Failure [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating the hemodynamic effects of spironolactone in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: University of Toledo Health Science Campus | Conditions: Congestive Heart Failure | NA | Status: COMPLETED